Cormorant Asset Management, LP Ars Pharmaceuticals, Inc. Comm Transaction History
Cormorant Asset Management, LP
- $1.27 Billion
- Q4 2024
A detailed history of Cormorant Asset Management, LP transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Cormorant Asset Management, LP holds 500,000 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500,000Holding current value
$0% of portfolio
0.0%Shares
4 transactions